GEHC vs. SYK pairs trade: valuation gap and relative value case

Investing.com reports on a pairs trade involving GE HealthCare Technologies (GEHC) and Stryker Corp (SYK), two companies in the Healthcare Equipment & Supplies sector with similar hospital budget cycles. However, their valuations suggest they operate in different universes. GEHC currently trades at roughly half SYK's earnings multiple, indicating a notable discount despite being a company that spun out of GE just three years ago and has been steadily improving its margins.

The market may be pricing in skepticism towards GEHC's fundamentals, as the valuation gap between the two companies appears unjustified when considering their financials. SYK's higher earnings multiple may be justified by its superior quality, but the question remains whether the 2x earnings multiple for GEHC, which boasts 1.6x the Return on Invested Capital (ROIC) and 2.5x the revenue growth, is truly warranted.

A pairs trade is market-neutral, meaning the goal is to profit from the convergence of the valuation spread rather than the overall market direction. The current numbers suggest a 25.4% upside potential for GEHC relative to SYK, with the trade being profitable if GEHC outperforms SYK on a relative basis.

To manage risk, the stop-loss discipline stipulates that if the price-to-earnings (PE) spread widens beyond 20x (with SYK trading at 2.1x GEHC's multiple), the thesis should be reevaluated. This scenario could indicate a structural deterioration in GEHC that hasn't yet been reflected in the financials.

In summary, the pairs trade capitalizes on the valuation gap between GEHC and SYK, leveraging each company's traditional metrics. While SYK offers a quality premium, its valuation has likely overextended. The trade hinges on the relative performance of GEHC, which appears to offer more compelling value on paper.